A low molecular weight heparin (LMWH), which benefit from a heterogeneous mixture of polysaccharides by depolymerization of porcine mucosa heparin sodium extraction / purification and calcium salt conversion glycosaminoglycan sulfated. nadroparin calcium binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa) to thereby inhibit the final common pathway of the coagulation cascade and prevents the formation of a crosslinked fibrin clot. Check for active clinical trials using this agent. (NCI Thesaurus)